Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis
2006
Ertapenem Resistance among Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Isolates
2009
In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance
2007
Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure
2013
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Probing p53 biological functions through the use of genetically engineered mouse models
2005
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Nutraceuticals: Facts and fiction
2007 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Resistance to echinocandin-class antifungal drugs
2007
First national surveillance of susceptibility of extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel
2007
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
2007
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
2007 Standout
Candida albicanspathogenicity mechanisms
2013 Standout
Methods for in vitro evaluating antimicrobial activity: A review
2015 Standout
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
2017
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
2012 Standout
How to improve R&D productivity: the pharmaceutical industry's grand challenge
2010 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Current status of antifungal susceptibility testing methods
2007
Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk
2004
The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates
2007
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center
2011
Coenzyme Q10 and exercise training in chronic heart failure
2006
Emerging echinocandins for treatment of invasive fungal infections
2006
Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
2011
Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era
2015
Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: A randomized double-blind study
2007
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
2016 Standout
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Echinocandins for Candidemia in Adults without Neutropenia
2006
Properties and potential of ertapenem
2003
Oncogenicity evaluation of resveratrol in p53(±) (p53 knockout) mice
2006
Amphotericin B and Caspofungin Resistance in Candida glabrata Isolates Recovered from a Critically Ill Patient
2006
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
The Spread ofKlebsiella pneumoniaeCarbapenemase–ProducingK. pneumoniaeto Upstate New York
2006
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
2009 Standout
Comparative Review of the Carbapenems
2007
Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes
2012 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Recent advances in antifungal chemotherapy
2007
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients
2007 Standout
Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches
2012
Invasive Fungal Pathogens: Current Epidemiological Trends
2006
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Contemporary Tools for the Diagnosis and Management of Invasive Mycoses
2006
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying FKS Mutant Candida glabrata Strains and Echinocandin Resistance
2013
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
The Proline 12 Alanine Substitution in the Peroxisome Proliferator–Activated Receptor-γ2 Gene Is Associated With Lower Lipoprotein Lipase Activity in Vivo
2002
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp
2009
Rational Design of Doravirine: From Bench to Patients
2019
Hidden Killers: Human Fungal Infections
2012 Standout
The Evolving Role of Antifungal Susceptibility Testing
2013
Works of Lori Mixson being referenced
In vitroActivity of Ertapenem against Common Clinical Isolates in Relation to Human Pharmacokinetics
2002
Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats
2003
Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals
2011
Use of surrogate antimicrobial agents to predict susceptibility to ertapenem
2002
Association of lipoprotein lipase gene polymorphisms with coronary artery disease
1999
Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome
2005
p53 +/- Hemizygous Knockout Mouse: Overview of Available Data
2001
Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans
2018
Efavirenz modulation of sleep spindles and sleep spectral profile
2014